Decheng Capital LLC

Decheng Capital LLC is an Investment Adviser institutional filer with the SEC under CIK 2010850, reporting 14 portfolio positions, with 17 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

• State of incorporation: E9
• Filing type: 13F-HR
• Latest reporting period: 2026-06-30
• Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Decheng Capital LLC's most recent 13F filing, ranked by reported market value.

1. CG ONCOLOGY INC (CGON)
2. Nuvation Bio Inc. (NUVB)
3. AARDVARK THERAPEUTICS INC (AARD)
4. Aclaris Therapeutics, Inc. (ACRS)
5. Upstream Bio Inc. (UPB)
6. Arcus Biosciences, Inc (RCUS)
7. Equillium Inc. (EQ)
8. REVOLUTION MEDICINES INC(NSM) (RVMD)
9. Lyell Immunopharma, Inc. (LYEL)
10. BeyondSpring Inc. (BYSI)